Related references
Note: Only part of the references are listed.Antimicrobial Therapy for Life-threatening Infections: Speed is Life
Duane J. Funk et al.
CRITICAL CARE CLINICS (2011)
Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study
Vered Hiba et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A
Alejandro Rodriguez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection
Ryan Zarychanski et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
The Natural Viral Load Profile of Patients With Pandemic 2009 Influenza A(H1N1) and the Effect of Oseltamivir Treatment
Iris W. Li et al.
CHEST (2010)
Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection
Kelvin K. W. To et al.
CLINICAL INFECTIOUS DISEASES (2010)
Effects of Early Oseltamivir Therapy on Viral Shedding in 2009 Pandemic Influenza A (H1N1) Virus Infection
Li M. Ling et al.
CLINICAL INFECTIOUS DISEASES (2010)
Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
Alicia M. Siston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Effectiveness of Antiviral Treatment in Human Influenza A(H5N1) Infections: Analysis of a Global Patient Registry
Wiku Adisasmito et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California
Janice K. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Outcomes of adults hospitalised with severe influenza
N. Lee et al.
THORAX (2010)
The Effect of Time to Antifungal Therapy on Mortality in Candidemia Associated Septic Shock
Gourang P. Patel et al.
AMERICAN JOURNAL OF THERAPEUTICS (2009)
Immortal time bias in critical care research: Application of time-varying Cox regression for observational cohort studies
Ayumi K. Shintani et al.
CRITICAL CARE MEDICINE (2009)
Critically Ill Patients With 2009 Influenza A(H1N1) in Mexico
Guillermo Dominguez-Cherit et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza
Nelson Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009.
Seema Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and Risk Factors for Fatal Outcome
Wanna Hanshaoworakul et al.
PLOS ONE (2009)
Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes
N. Lee et al.
CLINICAL INFECTIOUS DISEASES (2008)
Early intravenous unfractionated heparin and mortality in septic shock
Ryan Zarychanski et al.
CRITICAL CARE MEDICINE (2008)
Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada
Allison McGeer et al.
CLINICAL INFECTIOUS DISEASES (2007)
Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes
Eric A. Orzeck et al.
CLINICAL THERAPEUTICS (2007)
Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections:: Impact of delayed appropriate antibiotic selection
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Immortal time bias in observational studies of drug effects
Samy Suissa
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
Kevin W. Garey et al.
CLINICAL INFECTIOUS DISEASES (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock:: Association with serum lactate and inflammatory cytokine levels
A Kumar et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Pseudomonas aeruginosa bacteremia:: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome
CI Kang et al.
CLINICAL INFECTIOUS DISEASES (2003)
Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations
L Kaiser et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Early administration of oral oseltamivir increases the benefits of influenza treatment
FY Aoki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Clinical benefits with oseltamivir in treating influenza in adult populations - Results of a pooled and subgroup analysis
S Singh et al.
CLINICAL DRUG INVESTIGATION (2003)
Safety and pharmacology of oseltamivir in clinical use
R Dutkowski et al.
DRUG SAFETY (2003)
ICU-acquired nosocomial infection:: Impact of delay of adequate antibiotic treatment
T Mathevon et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2002)
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia
M Iregui et al.
CHEST (2002)
Treatment of acute hepatitis C with interferon alfa-2b
E Jaeckel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
KG Nicholson et al.
LANCET (2000)
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial
JJ Treanor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
